D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Community Health Systems
CYH
$409M
| $27.4M | 0.03% |
6,231,545
-368,905
| -6% | -$1.62M |
|
402
HubSpot
HUBS
$25.8B
| $27.3M | 0.03% |
51,379
-19,562
| -28% | -$10.4M |
|
403
Duke Energy
DUK
$94.4B
| $27.3M | 0.03% |
304,353
-213,571
| -41% | -$19.2M |
|
404
Estee Lauder
EL
$31.5B
| $27.3M | 0.03% |
138,859
-402,058
| -74% | -$79M |
|
|
CTEV
405
Claritev Corporation
CTEV
$1.04B
| $27.3M | 0.03% |
322,901
-3,787
| -1% | -$320K |
|
|
NVRO
406
DELISTED
NEVRO CORP.
NVRO
| $27.2M | 0.03% |
1,070,979
+268,384
| +33% | +$6.82M |
|
407
Norfolk Southern
NSC
$61.1B
| $27.1M | 0.03% |
119,546
+12,441
| +12% | +$2.82M |
|
408
Transmedics
TMDX
$3.67B
| $27M | 0.03% |
321,975
-119,999
| -27% | -$10.1M |
|
409
Take-Two Interactive
TTWO
$45B
| $27M | 0.03% |
183,424
-466
| -0.3% | -$68.6K |
|
410
Workiva
WK
$4.24B
| $27M | 0.03% |
265,497
+4,245
| +2% | +$432K |
|
411
Novartis
NVS
$245B
| $26.9M | 0.03% |
266,942
+264,142
| +9,434% | +$26.7M |
|
412
Peabody Energy
BTU
$2.25B
| $26.8M | 0.03% |
1,238,414
-184,164
| -13% | -$3.99M |
|
413
Synaptics
SYNA
$2.67B
| $26.8M | 0.03% |
313,379
+207,527
| +196% | +$17.7M |
|
414
Targa Resources
TRGP
$35.2B
| $26.7M | 0.03% |
351,232
+198,451
| +130% | +$15.1M |
|
415
Vertiv
VRT
$52.2B
| $26.6M | 0.03% |
1,073,162
+768,757
| +253% | +$19M |
|
416
UBS Group
UBS
$127B
| $26.5M | 0.03% |
1,307,448
+1,256,871
| +2,485% | +$25.5M |
|
417
Kinder Morgan
KMI
$60.8B
| $26.5M | 0.03% |
1,538,429
-326,944
| -18% | -$5.63M |
|
418
Bausch Health
BHC
$2.64B
| $26.2M | 0.03% |
3,271,607
-1,356,903
| -29% | -$10.9M |
|
419
Sleep Number
SNBR
$211M
| $26.1M | 0.03% |
955,525
+485,455
| +103% | +$13.2M |
|
420
Roper Technologies
ROP
$55.2B
| $25.9M | 0.03% |
53,879
-299
| -0.6% | -$144K |
|
421
Yum China
YUMC
$16.2B
| $25.9M | 0.03% |
+457,981
| New | +$25.9M |
|
|
KRTX
422
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $25.9M | 0.03% |
119,326
+11,907
| +11% | +$2.58M |
|
423
Ollie's Bargain Outlet
OLLI
$7.95B
| $25.8M | 0.03% |
445,518
-57,979
| -12% | -$3.36M |
|
424
Invesco
IVZ
$9.88B
| $25.6M | 0.03% |
1,525,010
-95,201
| -6% | -$1.6M |
|
425
RLI Corp
RLI
$6.08B
| $25.6M | 0.03% |
375,520
+307,652
| +453% | +$21M |
|